Analysts: ResMed Inc (RMD.N)
RMD.N on New York Stock Exchange
48.38USD
1 Aug 2013
48.38USD
1 Aug 2013
Price Change (% chg)
$0.73 (+1.53%)
$0.73 (+1.53%)
Prev Close
$47.65
$47.65
Open
$48.50
$48.50
Day's High
$49.41
$49.41
Day's Low
$47.90
$47.90
Volume
522,336
522,336
Avg. Vol
238,662
238,662
52-wk High
$51.39
$51.39
52-wk Low
$31.08
$31.08
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.56 | June | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 1 | 1 | 1 |
| (2) OUTPERFORM | 4 | 3 | 3 | 3 |
| (3) HOLD | 7 | 7 | 7 | 9 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.38 | 2.55 | 2.55 | 2.62 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 7 | 371.53 | 375.00 | 367.00 | 368.51 |
| Quarter Ending Dec-13 | 7 | 410.84 | 422.00 | 405.55 | 397.45 |
| Year Ending Jun-13 | 13 | 1,514.19 | 1,545.00 | 1,505.44 | 1,479.62 |
| Year Ending Jun-14 | 13 | 1,657.12 | 1,702.00 | 1,624.20 | 1,613.01 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 7 | 0.56 | 0.61 | 0.53 | -- |
| Quarter Ending Dec-13 | 7 | 0.63 | 0.68 | 0.59 | 0.48 |
| Year Ending Jun-13 | 10 | 2.25 | 2.27 | 2.18 | 1.91 |
| Year Ending Jun-14 | 10 | 2.52 | 2.75 | 2.38 | 2.09 |
| LT Growth Rate (%) | 4 | 16.40 | 20.01 | 15.00 | 15.77 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 387.68 | 383.58 | 4.10 | 1.06 |
| Quarter Ending Dec-12 | 363.76 | 376.54 | 12.78 | 3.51 |
| Quarter Ending Sep-12 | 341.14 | 339.73 | 1.41 | 0.41 |
| Quarter Ending Jun-12 | 368.36 | 371.93 | 3.57 | 0.97 |
| Quarter Ending Mar-12 | 339.56 | 349.07 | 9.51 | 2.80 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.57 | 0.59 | 0.02 | 4.24 |
| Quarter Ending Dec-12 | 0.51 | 0.54 | 0.03 | 5.76 |
| Quarter Ending Sep-12 | 0.46 | 0.50 | 0.04 | 9.79 |
| Quarter Ending Jun-12 | 0.49 | 0.55 | 0.06 | 12.57 |
| Quarter Ending Mar-12 | 0.41 | 0.46 | 0.05 | 12.20 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 371.53 | 373.07 | 373.28 | 373.28 | 368.51 |
| Quarter Ending Dec-13 | 410.84 | 412.26 | 412.26 | 412.26 | 397.45 |
| Year Ending Jun-13 | 1,514.19 | 1,514.34 | 1,514.41 | 1,513.68 | 1,479.62 |
| Year Ending Jun-14 | 1,657.12 | 1,660.59 | 1,664.91 | 1,665.14 | 1,613.01 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.56 | 0.55 | 0.55 | 0.55 | -- |
| Quarter Ending Dec-13 | 0.63 | 0.61 | 0.61 | 0.61 | 0.48 |
| Quarter Ending Jun-13 | 2.25 | 2.25 | 2.25 | 2.25 | 1.91 |
| Quarter Ending Jun-14 | 2.52 | 2.49 | 2.49 | 2.48 | 2.09 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 3 | 0 | 4 |
| Quarter Ending Dec-13 | 0 | 3 | 0 | 4 |
| Year Ending Jun-13 | 0 | 2 | 1 | 2 |
| Year Ending Jun-14 | 0 | 3 | 0 | 4 |
| Earnings | ||||
| Quarter Ending Sep-13 | 2 | 0 | 2 | 0 |
| Quarter Ending Dec-13 | 2 | 0 | 2 | 1 |
| Year Ending Jun-13 | 1 | 2 | 2 | 3 |
| Year Ending Jun-14 | 2 | 1 | 3 | 1 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (RMD). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: MacroRisk Analytics/EconomicInvestor
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates